On the announcement date, GeoYoung, the largest healthcare platform in South Korea, disclosed that it has signed a memorandum of understanding (MOU) with A.D Cure, a digital healthcare company specializing in voice‑based artificial intelligence.
Under the agreement, the parties will discuss cooperation on the sale, distribution and commercialization of A.D Cure’s voice‑AI solution “Heart to Voice (H2V).”
The collaboration will also cover the sale and distribution of A.D Cure’s existing digital health products and services, securing market‑entry channels, marketing and sales activities, joint development and enhancement of products and services, and the exploration of new business models.
The H2V solution is intended for everyday use (the source text cuts off here).
Research & ReportsSep 12, 2026•1 min read
GeoYoung partners with A.D Cure to launch Voice AI solution H2V
GeoYoung, Korea’s largest healthcare platform, has signed an MOU with voice AI digital health firm A.D Cure to discuss sales, distribution and commercialization of the ‘Heart to Voice (H2V)’ solution and other collaborative opportunities.
Compiled by the PharmaCountry team · Source: KPA News
Ratings
(0)
(0)
(0)
(0)
(0)
More articles
View all insightsResearch & Reports
Global Finished Dosage Manufacturing Landscape 2026
Oct 5, 2026
Regulatory UpdatesKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
Sep 28, 2026
AnalysisPharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
Sep 28, 2026
Leave your rating